New study sheds light on the gender disparity in autoimmune disorders
Stanford University researchers discover how the female X chromosome affects the immune system
Washington — In a groundbreaking study, researchers from Stanford University have uncovered a potential explanation for why women are more susceptible to autoimmune diseases than men. The study, published in the journal Cell, suggests that the presence of an extra X chromosome in females plays a significant role in the development of these diseases.
Autoimmune disorders, such as lupus, rheumatoid arthritis, and multiple sclerosis, affect an estimated 24 to 50 million Americans. Women make up approximately 80% of these patients, a phenomenon that has puzzled scientists for decades. One theory proposed by researchers was that the additional X chromosome in females might contribute to the disparity, as males possess only one X and one Y chromosome.
The research conducted by Stanford University reveals that the extra X chromosome does indeed play a role, but in an unexpected way. The DNA in each cell is carried in 23 pairs of chromosomes, including the pair that determines biological sex. Females have two X chromosomes, and each cell must deactivate one of them to prevent an overdose of genes. This process, known as X-chromosome inactivation, is regulated by a unique RNA molecule called Xist.
Dr. Howard Chang, a dermatologist at Stanford, and his team discovered that Xist attracts proteins that bind to it, forming clumps along the extra X chromosome. These proteins are related to skin-related autoimmune disorders, where the immune system mistakenly attacks normal proteins. Further investigation revealed that Xist could potentially organize proteins in a way that activates the immune system.
However, the presence of Xist alone is not enough to cause autoimmune disease in all women. Scientists believe that a combination of genetic susceptibility and environmental triggers is necessary for the immune system to go awry. To test this hypothesis, the researchers engineered male mice to produce Xist without silencing their only X chromosome. These mice developed lupus-like autoimmunity when triggered, comparable to what is observed in females.
The findings of this study have significant implications for diagnosing and treating autoimmune diseases. By examining blood samples from 100 patients, the researchers found autoantibodies targeting proteins associated with Xist that were not previously linked to autoimmune disorders. This discovery suggests that standard tests for autoimmunity, which were developed using male cells, may not be comprehensive enough to capture the full range of diseases.
While further research is needed, these findings provide a potential pathway for improved diagnosis and treatment. Understanding the role of Xist and its associated proteins allows doctors to identify disease patterns more accurately and tailor treatments accordingly. Additionally, this research opens up possibilities for future interventions that could interrupt the disease process.
Dr. E. John Wherry, an immunologist from the University of Pennsylvania who was not involved in the study, praised the findings, stating that they transform the understanding of autoimmunity and the male-female bias. He believes that this research will help clinicians diagnose patients who appear clinically and immunologically distinct but share common features within the Xist complex.
As the medical community continues to unravel the complexities of autoimmune diseases, this study provides a crucial piece of the puzzle. While significant work remains, the potential for improved detection, treatment, and perhaps even prevention is promising.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.